Glutaraldehyde erythropoietin protects kidney in ischaemia/reperfusion injury without increasing red blood cell production

BACKGROUND AND PURPOSE: Recombinant human erythropoietin (rHuEPO) is currently the mainstay of renal anaemia treatment. Recently, rHuEPO has been shown to provide pleiotrophic tissue protection in various pathological conditions. However, the benefits of rHuEPO beyond anaemia treatment are limited b...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Chattong, S, Tanamai, J, Kiatsomchai, P, Nakatsu, M, Sereemaspun, A, Pimpha, N, Praditpornsilpa, K, Rojanathanes, R, Sethpakadee, A, Tungsanga, K, Eiam-Ong, S, Manotham, K
Formato: Artigo
Idioma:Inglês
Publicado: Blackwell Publishing Ltd 2013
Assuntos:
Research Papers
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3570014/
https://ncbi.nlm.nih.gov/pubmed/22861820
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1476-5381.2012.02123.x
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares